MMM Medicine Made to Measure
MMM Medicine Made to Measure is an Innovative Training Network funded by the European Union under the Horizon Europe Marie Skłodowska-Curie Actions scheme.
Its aim is to develop single patient tailored antisense oligonucleotide (ASO) treatments for patients with nano-rare disease mutations. For this purpose, 10 doctoral candidates will be recruited to research the core modules of tailored ASO treatments to nano-rare RND patients
News
MMM General Assembly
From 7 to 8 June 2024, we organised MMM’s first…
First Business Training for Doctoral Candidates
The seven Doctoral Candidates recruited for MMM so far had…
Start of MMM
The MMM Innovative Training Network started on 1st October 2023…